Daivobet® gel

DRUG4 trials

Sponsors

LEO Pharma

Conditions

Plaque PsoriasisPsoriasis VulgarisSkin and Connective Tissue Diseases

Phase 2

A Psoriasis Plaque Test Trial With LP0113 Spray in Patients With Psoriasis Vulgaris (LP0113-1123)

CompletedNCT02416258

LEO PharmaSkin and Connective Tissue Diseases

Start: 2015-04-30End: 2015-06-30Updated: 2025-02-24

Phase 3

Patient Insights Following Use of LEO 90100 Aerosol Foam and Daivobet® Gel in Subjects With Psoriasis Vulgaris

CompletedNCT02310646

LEO PharmaPsoriasis Vulgaris

Start: 2015-01-31End: 2015-07-31Updated: 2025-03-10

Unknown Phase

Efficacy, Tolerability and Handling of Daivobet® Gel in Patients With Psoriasis Vulgaris

CompletedNCT01320774

LEO PharmaPsoriasis Vulgaris

Start: 2011-04-30End: 2012-01-31Updated: 2012-02-10

Non-interventional Study of Long-term Treatment of Psoriasis With Calcipotriol Plus Betamethasone in Gel Formulation

CompletedNCT01707368

LEO PharmaPlaque Psoriasis, Psoriasis Vulgaris

Start: 2012-10-31End: 2014-07-31Updated: 2018-09-24

Related Papers

Patients with psoriasis have different preferences for topical therapy, highlighting the importance of individualized treatment approaches: randomized phase IIIb PSO-INSIGHTFUL study.

2017-09-1431 citations